RetinalGenix Technologies (RTGN) Cash from Operations (QoQ) (2021 - 2026)
RetinalGenix Technologies (RTGN) Cash from Operations (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.82% |
| Dec 31, 2025 | -23.48% |
| Sep 30, 2025 | 25.34% |
| Jun 30, 2025 | 25.72% |
| Mar 31, 2025 | -0.45% |
| Dec 31, 2024 | 24.52% |
| Sep 30, 2024 | -70.54% |
| Jun 30, 2024 | 11.61% |
| Mar 31, 2024 | 43.52% |
| Dec 31, 2023 | -829.64% |
| Sep 30, 2023 | 132.10% |
| Jun 30, 2023 | -59.60% |
| Mar 31, 2023 | -133.48% |
| Dec 31, 2022 | 43.64% |
| Sep 30, 2022 | -471.61% |
| Jun 30, 2022 | 89.34% |
| Mar 31, 2022 | 66.69% |
| Dec 31, 2021 | -36.62% |
| Sep 30, 2021 | 19.59% |
| Jun 30, 2021 | 33.75% |